Anecortave acetate for treating or preventing choroidal neovascularization.

[1]  W. Feuer,et al.  Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice. , 2006, Investigative ophthalmology & visual science.

[2]  X. Gu,et al.  Local Delivery of Anecortave Acetate Inhibits the Expression of Retinal IGF–1/IGF–1 Receptor in the Rat OIR Model , 2005 .

[3]  Jonathan D. Walker,et al.  Corticosteroids in posterior segment disease: an update on new delivery systems and new indications , 2004, Current opinion in ophthalmology.

[4]  J. Penn,et al.  Inhibition Of VEGF–Induced Endothelial Cell Poliferation And Differentiation By Steroidal And Non–steroidal Cox Inhibitors With Variable Cox–1/Cox–2 Selectivity , 2004 .

[5]  R. Landers,et al.  Local delivery of anecortave acetate inhibits laser–induced choroidal neovascularization (CNV) in the mouse , 2004 .

[6]  R. Danis,et al.  Squalamine Lactate Reduces Choroidal Neovascularization in a Laser-Injury Model in the Rat , 2003, Retina.

[7]  J. Slakter,et al.  Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. , 2003, Ophthalmology.

[8]  A. Clark,et al.  Design of a Specialized Cannula for Posterior Juxtascleral Delivery of Anecortave Acetate to the Retina for Treatment CNV Associated with Age-Related Macular Degeneration (AMD) , 2003 .

[9]  J. Slakter,et al.  ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD): Interim (Month 6) Analysis of Clinical Safety and Efficacy , 2003, Retina.

[10]  A. Brucker,et al.  Ocular manifestations of remote lightning strike. , 2002, Retina.

[11]  K. Holroyd,et al.  EFFECT OF SQUALAMINE ON IRIS NEOVASCULARIZATION IN MONKEYS , 2002, Retina.

[12]  Verteporfin Roundtable Participants.  GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES , 2002, Retina.

[13]  A. Clark,et al.  Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. , 1999, Investigative ophthalmology & visual science.

[14]  A. Clark.  AL-3789: a novel ophthalmic angiostatic steroid. , 1997, Expert opinion on investigational drugs.

[15]  B. Griffin,et al.  Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. , 1997, Investigative ophthalmology & visual science.

[16]  J. Penn,et al.  Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat , 1994, Pediatric Research.

[17]  Michael S. Pepper,et al.  The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth , 1994, Nature.

[18]  J. Mcinnes,et al.  The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. , 1993, Experimental eye research.

[19]  J. Folkman,et al.  Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. , 1991, Investigative ophthalmology & visual science.

[20]  S. Szabó,et al.  A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. , 1985, Science.

[21]  D. Phelps,et al.  Vitamin E in kitten oxygen-induced retinopathy. II. Blockage of vitreal neovascularization. , 1979, Archives of ophthalmology.

[22]  J. Slakter,et al.  Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. , 2006, Ophthalmology.

[23]  P. Wiedemann,et al.  Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  V. Rajaratnam,et al.  The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. , 2001, Investigative ophthalmology & visual science.

[25]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.